Clearmind Medicine (CMND) Operating Expenses (2022 - 2026)

Clearmind Medicine (CMND) has reported Operating Expenses for 5 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 20.22% year-over-year to $1.6 million; the trailing twelve-month figure through Apr 2026 stood at $8.1 million (up 38.13% YoY), and the FY2025 full-year result was $5.7 million, down 1.35% from the prior year.
• Operating Expenses fell to $1.6 million in Q2 2026 per CMND's latest filing, from $3.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $3.7 million in Q1 2026 and bottomed at $1.1 million in Q3 2023.
• Historically, Operating Expenses has averaged $1.6 million across 5 years, with a median of $1.5 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses declined 24.5% in 2024, then surged 144.62% in 2026.
• Over 5 years, Operating Expenses stood at $1.2 million in 2022, then jumped by 48.47% to $1.7 million in 2023, then dropped by 7.32% to $1.6 million in 2024, then decreased by 8.19% to $1.5 million in 2025, then rose by 7.89% to $1.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $1.6 million, $3.7 million, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.